HomeClinical TopicsFDA clears stereotactic radiotherapy system for treating breast cancer

FDA clears stereotactic radiotherapy system for treating breast cancer

Author(s):

On Dec. 22, the U.S. Food and Drug Administration (FDA) cleared the GammaPod system, a new noninvasive stereotactic radiotherapy system for treating breast cancer. However, it’s not as effective as whole breast radiation therapy, so isn’t intended to replace that.

Read more via Fda.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

menopause and sleep problems

Menopause and Sleep Problems

Data shows that sleep disturbances increase in prevalence during the menopausal transition, with the most common complaint being nighttime awakenings. Take our quick three-question survey...